References
- Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7: 97–110
- Packer L, Weber S U, Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr 2001; 131: 369S–373S
- Trachootham D, Lu W, Ogasawara M A, Nilsa R D, Huang P. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343–1374
- Marnett L J. Lipid peroxidation – DNA damage by malondialdehyde. Mutat Res 1999; 424: 83–95
- Sharma A, Tripathi M, Satyam A, Kumar L. Study of antioxidant levels in patients with multiple myeloma. Leuk Lymphoma 2009, in press
- Chen Q, Espey M G, Sun A Y, Lee J H, Krishna M C, Shacter E, et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA 2007; 104: 8749–8754
- Grad J M, Bahlis N J, Reis I, Oshiro M M, Dalton W S, Boise L H. Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells. Blood 2001; 98: 805–813
- Cenci S, Sitia R. Managing and exploiting stress in the antibody factory. FEBS Lett 2007; 581: 3652–3657